[1] |
Nigwekar SU, Kroshinsky D, Nazarian RM, et al. Calciphylaxis: risk factors, diagnosis, and treatment[J]. Am J Kidney Dis, 2015, 66(1): 133-146.
|
[2] |
Monegal A, Peris P, Alsina M, et al. Development of multiorganic calciphylaxis during teriparatide, vitamin D, and calcium treatment[J]. Osteoporos Int, 2016, 27(8): 2631-2634.
|
[3] |
Verma DK, Thelekkat Y, Bansal S. Metastatic calcification of floor of the mouth secondary to chronic renal failure-report of a rare case with atypical presentation[J]. Dentomaxillofac Radiol, 2015, 44(5): 20140023.
|
[4] |
Nigwekar SU. Calciphylaxis. Curr Opin Nephrol Hypertens[J]. 2017, 26(4): 276-281.
|
[5] |
Brandenburg VM, Kramann R, Rothe H, et al. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry[J]. Nephrol Dial Transplant, 2017, 32(1): 126-132.
|
[6] |
Verma DK, Thelekkat Y, Bansal S. Metastatic calcification of floor of the mouth secondary to chronic renal failure-report of a rare case with atypical presentation[J]. Dentomaxillofac Radiol, 2015, 44(5): 20140023.
|
[7] |
Disthabanchong S. Phosphate and Cardiovascular Disease beyond Chronic Kidney Disease and Vascular Calcification[J]. Int J Nephrol, 2018, 2018: 3162806.
|
[8] |
Gutierrez O, Isakova T, Rhee E, Shah A, et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease[J]. J Am Soc Nephrol, 2005, 16(7): 2205-22015.
|
[9] |
Pereira RC, Juppner H, Azucena-Serrano CE, et al. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease[J]. Bone 2009, 45(6): 1161-1168.
|
[10] |
Isakova T, Wahl P, Vargas GS, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease[J]. Kidney Int, 2011, 79(12): 1370-1378.
|
[11] |
Ketteler M, Rothe H, Krüger T, et al. Mechanisms and treatment of extraosseous calcification in chronic kidney disease[J]. Nat Rev Nephrol, 2011, 7(9): 509-516.
|
[12] |
Del Campo C, Weinstein P, Kunnelis C, DiStefano P, Ebers GM. Coconut atrium: transmural calcification of the entire left atrium[J]. Tex Heart Inst J, 2000, 27(1): 49-51.
|
[13] |
Vallejo JL, Merino C, González-Santos JM,et al. Massive calcification of the left atrium: surgical implications[J]. Ann Thorac Surg, 1995, 60(5): 1226-1229.
|
[14] |
Montes L, Rodriguez JE, Carnero M. Giant right atrial dilation and left atrial calcification[J]. Ann Thorac Surg, 2011, 91(5): e80.
|
[15] |
Gutiérrez OM, Januzzi JL, Isakova T,et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation[J]. 2009, 19, 119(19): 2545-2552.
|
[16] |
Xuying Zhu, Hong Cai, Minxia Zhu, et al. Association of abdominal aortic calcification estimated by plain radiography with outcomes in hemodialysis patients: a six-year follow-up study[J]. Nephrology (Carlton), 2019, 19.
|
[17] |
Cowlam TE, Bucknall TE. Cutaneous ectopic breast calcification in a haemodialysis patient[J]. Breast, 2003, 12(5): 342-344.
|
[18] |
Yuan H, Shih-Hua L. Diffuse peritoneal calcification[J]. Turk J Gastroenterol, 2014, 25(4): 438-439.
|
[19] |
王莉,李贵森,刘志红. 中华医学会肾脏病学分会《慢性肾脏病矿物质和骨异常诊治指导》[J]. 肾脏病与透析肾移植杂志, 2013, 22(6): 554-559.
|